Sattva Neelapu, MD


Drs. Sattva Neelapu and Nathan Fowler discuss how CAR T therapy is changing the treatment paradigm across lymphoma with a broad clinical research effort that is only just beginning. The unique toxicities associated with cell-based therapies and their management have become a major focus of ongoing studies.